Evaluating adherence to ocular hypotensives using the Travatan dosing aid
Leslie O'Dell1, Amy L Hennessy2,3, Alan L Robin2–41May Eye Care Center, Hanover, PA, USA; 2Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; 3Glaucoma Specialists, Baltimore, MD, USA; 4Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, MD,...
Main Authors: | O'Dell L, Hennessy AL, Robin AL |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-01-01
|
Series: | Clinical Optometry |
Online Access: | http://www.dovepress.com/evaluating-adherence-to-ocular-hypotensives-using-the-travatan-dosing--a9090 |
Similar Items
-
Adherence to ocular hypotensive therapy: patient health education needs and views on group education
by: Waterman H, et al.
Published: (2013-01-01) -
The hypotensive effect of verapamil eye drops on ocular hypertension
by: Goyal J, et al.
Published: (1989-01-01) -
Dose-dependent Spasmolytic, Bronchodilator, and Hypotensive Activities of L.
by: Fatima Saqib, et al.
Published: (2022-02-01) -
Treatment with budesonide/formoterol pressurized metered-dose inhaler in patients with asthma: a focus on patient-reported outcomes
by: Richard D O'Connor
Published: (2011-01-01) -
Ocular hypotensive efficacy of a new liposomal latanoprost formulation administered by different routes for experimental ocular hypertension
by: I. M. Mikheytseva, et al.
Published: (2022-04-01)